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Summary
Mitochondria are dynamic organelles, undergoing both
fission and fusion regularly in interphase cells. Mitochon-
drial fission is thought to be part of a quality-control mecha-
nism whereby damaged mitochondrial components are
segregated from healthy components in an individual mito-
chondrion, followed by mitochondrial fission and degrada-
tion of the damaged daughter mitochondrion [1]. Fission
also plays a role in apoptosis [2]. Defects in mitochondrial
dynamics can lead to neurodegenerative diseases such as
Alzheimer’s disease [3]. Mitochondrial fission requires the
dynamin GTPase Drp1, which assembles in a ring around
the mitochondrion and appears to constrict both outer and
inner mitochondrial membranes [4]. However, mechanisms
controlling Drp1 assembly on mammalian mitochondria
are unclear. Recent results show that actin polymerization,
driven by the endoplasmic reticulum-bound formin protein
INF2, stimulates Drp1 assembly at fission sites [5]. Here,
we show that myosin II also plays a role in fission. Chemical
inhibition by blebbistatin or small interfering RNA (siRNA)-
mediated suppression of myosin IIA or myosin IIB causes
an increase in mitochondrial length in both control cells
and cells expressing constitutively active INF2. Active
myosin II accumulates in puncta onmitochondria in an actin-
and INF2-dependentmanner. In addition,myosin II inhibition
decreases Drp1 association with mitochondria. Based on
these results, we propose a mechanistic model in which
INF2-mediated actin polymerization leads to myosin II
recruitment and constriction at the fission site, enhancing
subsequent Drp1 accumulation and fission.Results and Discussion
While Drp1 clearly is essential for mitochondrial fission,
several studies have suggested that an initial Drp1-indepen-
dent constriction stepmight be required prior to Drp1 accumu-
lation [6–8]. In a previous publication, we presented data
showing that actin polymerization at this site, initiated by
INF2 on the endoplasmic reticulum (ER) membrane, provided
the force to drive this initial constriction, with the pointed
ends of these actin filaments pushing the mitochondrial outer
membrane inward [5]. This model bears some resemblance to
other polymerization-based force generation events, such as
leading-edge extension in cell motility or the initial steps of
endocytosis [9]. Another actin-based mechanism for force
generation, however, is the use of myosin II to constrict anti-
parallel actin filament networks [10], such as in muscle
contraction, stress fiber contraction [11], and possibly cytoki-
nesis [12]. Indeed, recent results suggest a role for myosins in
mammalian mitochondrial fission, as suppression of myosin*Correspondence: henry.higgs@dartmouth.eduregulatory light chain or inhibition of myosin light-chain kinase
causes increases in mitochondrial length [13]. Here, we
address the role ofmyosin II in this process and its relationship
to INF2 and Drp1.
Myosin II Inhibition Increases Mitochondrial Length
As an initial test of myosin II involvement in mitochondrial
dynamics, we used the small-molecule myosin II inhibitor
blebbistatin [14] on U2OS human osteosarcoma cells and
measured lengths of peripheral mitochondria. Short-term
blebbistatin treatment results in decreased stress fiber density
(see Figure S1A available online) and a significant increase in
mean mitochondrial length from 5.29 to 6.77, 8.28, and
7.57 mm at 30, 60, and 120 min, respectively (Figure 1). This
is likely an underestimate of mitochondrial length change,
because many of the mitochondria become too long to mea-
sure after blebbistatin treatment, with one extremity being
obscured in the perinuclear region. Even so, analysis of the
histogram of mitochondrial lengths shows a significant
increase in the longest mitochondria upon blebbistatin treat-
ment, with the percentage of mitochondria > 10 mm increasing
from 13.6 to 29.2, 43.2, and 40.3 at the three time points tested
(Figure S1B). Interestingly, inhibition of Arp2/3 complex with
the small-molecule inhibitor CK666 does not affect mitochon-
drial length (Figure 1C), despite its potent inhibition of lamelli-
podia under these conditions (Figures S1C and S1D). This
result is significant, because it suggests that INF2 is acting in
an Arp2/3-independent manner in producing the actin fila-
ments that serve in mitochondrial fission, making the process
different from others in which formins act in concert with
Arp2/3 complex [15].
We have previously shown that the constitutively active
A149D mutant of INF2-CAAX (INF2-A149D) causes a signifi-
cant mitochondrial length decrease and enriches at fission
sites [5]. To test whether myosin II inhibition reverses this
effect, we treated INF2-A149D-transfected U2OS cells with
blebbistatin and measured peripheral mitochondrial length.
As observed previously, INF2-A149D expression decreases
mitochondrial length by >2-fold (Figure 1B). Blebbistatin treat-
ment partially reverses this effect, with mitochondrial lengths
of 2.18, 3.87, 4.42, and 4.49 mm at 0, 30, 60, and 120 min,
respectively (Figures 1A and 1B). The percentage of mitochon-
dria > 10 mm increases from 0% (INF2-A149D alone) to 7.3%,
10.1%, and 11.8% for 30, 60, and 120 min, respectively.
While blebbistatin displays specificity for myosin II over
three other myosin classes (I, V, and X) [14], most of the 20+
classes of mammalian myosins have not been tested for bleb-
bistatin sensitivity, raising the question of whether myosin II is
the target for blebbistatin’s effect on mitochondrial length. For
this reason, we also used an RNAi approach to suppress
expression of the two predominant nonmuscle myosin II pro-
teins, IIA and IIB, in U2OS cells. Treatment with specific small
interfering RNA (siRNA) oligonucleotides results in a >80%
reduction in the targeted myosin II, with no significant effect
on levels of the other myosin II or on two other myosins
(Figure S2).
Suppression of either myosin IIA (MIIA) or myosin IIB
(MIIB) results in a significant increase in mitochondrial length,
from 5.21 mm to 9.46 and 9.15 mm for IIA or IIB, respectively
Figure 1. Blebbistatin Treatment Increases Mito-
chondria Length in U2OS Cells
(A) Control U2OS cells (top) or cells expressing
GFP-INF2-A149D (bottom) were treated with
DMSO (left) or 50 mM blebbistatin (right) for
60 min and then stained with Mitotracker. Aster-
isks indicate cells expressing INF2-A149D (see
Figure S1 for GFP and actin staining). Scale bar
represents 10 mm.
(B) Quantification of mitochondrial length in
control or GFP-INF2-A149D-expressing cells,
treated with DMSO or 50 mM blebbistatin for the
indicated times. n = 103–344 mitochondria. p <
0.01 by Student’s t test.
(C) Quantification of mitochondrial length in con-
trol cells and cells treated with 200 mM CK689
(negative control compound) or CK666 (Arp2/3
complex inhibitor) for 60 min. n = 223–289 mito-
chondria.
Error bars represent SEM.
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410(Figures 2A and 2C). In addition, suppression of MIIA or MIIB
partially reverses the effect of INF2-A149D expression in
U2OS cells (Figures 2B and 2D), increasing average length
by 37% and 31%, respectively. Interestingly, combined sup-
pression of MIIA andMIIB does not cause an additive increase
in mitochondrial length above that caused by suppression of
either myosin individually (Figures 2B and 2D). However, limi-
tations in measuring long mitochondria, described above,
might hinder detection of such length changes. These results
suggest that myosin II plays a role in mitochondrial fission,
possibly utilizing the actin filaments generated by INF2.
Localization of Myosin II to Fission Sites
We next asked whether myosin II enriched at mitochondrial
fission sites, initially conducting immunofluorescence locali-
zation of endogenous protein. One issue with analyzing
myosin II localization is protein abundance, which causes
extensive staining throughout the cell and is particularly
intense on stress fibers. In this respect, we found that an anti-
body against serine 19-phosphorylated (activated) myosin
light chain (anti-P-MRLC) gave the lowest background staining
and thus was most suitable for examining mitochondrial local-
ization against a high background of stress fibers. Anti-P-
MRLC staining was detected at sites of mitochondrial
constriction (Figures 3A and 3B). In cells costained for
P-MRLC, mitochondria, and ER, P-MRLC accumulated at
constriction sites also enriched for ER (Figure 3A).
We also examined myosin II localization to mitochondria in
live cells, using a GFP fusion of MIIA expressed on a low-
expressing ‘‘speckle’’ promoter, since low expression was
found to be important in limiting artifactual myosin II-contain-
ing structures in previous studies [16]. Despite the confound-
ing influence of extensive accumulation on stress fibers,
GFP-MIIA accumulates transiently at mitochondrial constric-
tion sites undergoing fission (Figure 3C; Movie S1).
In another strategy to examine myosin II enrichment on
mitochondria, we used confocal microscopy to examine
more apical regions, avoiding the ventral surface that contains
a high density of actomyosin-based structures. The perinu-
clear region contains abundant mitochondria and is relatively
devoid of stress fibers. Though their lengths are difficult to
quantify due to their high density in this location, these
mitochondria appear generally shorter than peripheral mito-
chondria, similar to observations made in other cells [17].Anti-P-MRLC puncta enrich on these mitochondria (Figures
3D and S3A). Both actin depolymerization by latrunculin B
treatment and INF2 inhibition by siRNA cause significant de-
creases in the number of these puncta (Figures 3D and S3B).
Taken together, these results suggest that INF2-assembled
actin filaments are required for active myosin II association
with mitochondria.
Myosin II Inhibition Results in Decreased Mitochondrially
Associated Drp1
We have previously shown that INF2 suppression results in
decreased mitochondrially associated Drp1, suggesting that
INF2 acts upstream of Drp1 [5]. To test whether myosin II
acts at a similar stage in the process, we examined Drp1 distri-
bution after myosin II suppression. In control cells, Drp1 accu-
mulated as puncta on the mitochondrial surface (Figure 4A).
Suppression of either MIIA or MIIB significantly reduced the
number of mitochondrially associated Drp1 puncta (Figure 4).
Previous results have shown that myosin regulatory light chain
(MRLC) inhibition, either by siRNA suppression or by a myosin
light chain kinase (MLCK) inhibitor, increases mitochondrial
length and decreases mitochondrially associated Drp1 puncta
[13]. Since MRLC interacts with several classes of myosin [18]
(J. Sellers, personal communication), it was not clear which
myosin was the relevant motor. Our work shows that
myosin II specifically plays a role in this process.
Based on these results, we propose an alternative to our
previous actin polymerization-based model for initial mito-
chondrial constriction (Figure S4). INF2 activation at the ER-
mitochondrial interface results in actin filament assembly.
These filaments assume mixed orientations around the mito-
chondrion. Myosin II minifilaments are recruited to these actin
filaments, and their motor activity results in contraction of the
actin filament network either parallel or perpendicular to the
fission plane, constricting the mitochondrion. This initial
constriction allows Drp1 to bind and oligomerize at the
constriction site. A preconstriction event has been suggested
by previous findings [6–8]. Another possibility is that actin
and/or myosin II might help recruit Drp1 to the fission site by
direct binding, perhaps in conjunction with one of the outer
mitochondrial membrane proteins purported to act as a Drp1
receptor [19, 20]. Such binding has been suggested by cellular
experiments [13] and is consistent with direct binding between
dynamin and actin filaments [21].
Figure 2. Depletion of Myosin IIA or IIB Increases Mitochondrial Length
(A) MitoTracker staining of U2OS cells expressing the indicated siRNAs. Scale bar represents 10 mm.
(B) U2OS cells expressing control or MIIB siRNA were transfected with GFP-INF2-A149D (green) and stained with MitoTracker (red). Mitochondria alone are
also shown separately in the right panels.
(C and D) Quantification of mitochondrial lengths for experiments depicted in (A) and (B), respectively. Data are from three experiments; n = 261–368 mito-
chondria for (C) and 329–407 mitochondria for (D). Error bars represent SEM.
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do not think that this structure would consist of existing dorsal
or ventral stress fibers, since serum starvation in Dulbecco’s
modified Eagle’s medium (DMEM), which strongly reduces
these structures, actually causes mitochondria to become
shorter (data not shown), and since previous reports failed to
detect any association between mitochondria and stress
fibers [22]. Still, other myosin II-based structures, such as
cortical actomyosin [23], might contribute.
There are parallels between this model and assembly of
other contractile bundles requiring both a formin and
myosin II, such as cytokinetic ring assembly [12, 24]. Based
on these similarities, we refer to the process of INF2- and
myosin II-mediated mitochondrial constriction as ‘‘mitokine-
sis.’’ It is possible that myosin II is required not for mitochon-
drial constriction per se but for organization and stabilization
of the ring structure, similar to some models of cytokinesis
[25–27]. One clear difference between this process and cytoki-
nesis is that myosin recruitment to mitochondria depends on
actin filaments and formin, whereas myosin II is recruited to
the site of cytokinesis independently of actin where tested
[28–30].
It might seemcurious that bothMIIA andMIIB appear to play
roles in mitochondrial fission, but a series of studies shows
that the two myosins also play complementary roles in acto-
myosin fiber assembly during fibroblast polarization [16].
MIIA is the more dynamic protein, assembling into short acto-
myosin structures early in polarization, whereas MIIBstabilizes these structures at later time points. Studies with
genetically modified mice suggest that MIIA can replace
some but not all physiological functions of MIIB [31]. Thus, it
is possible that MIIA and MIIB play partially redundant roles
also in mitochondrial fission, perhaps forming hetero-oligo-
mers within the same minifilament. Alternately, it is possible
that there are separate pools of MIIA- and MIIB-dependent
fission events, but this seems less likely, particularly because
simultaneous suppression of both proteins does not result in
measurably longer mitochondria.
However, it is worth remembering that mitochondrial popu-
lations are heterogeneous, both within individual cell types
and between cell types [17]. There might also be multiple
mechanisms for inducing mitochondrial fission, although all
are likely to go through Drp1 ultimately. Our results suggest
that myosin II and INF2 act in the same fission mechanism,
but we do not discount the fact that other mechanisms inde-
pendent of myosin II, INF2, and actin might also exist for this
important process.
Finally, we do not rule out other configurations of actin fila-
ments and myosin that might produce similar constrictive
forces. One issue that might compromise a cytokinetic-like
actomyosin ring during mitochondrial fission is that the puri-
fied nonmuscle myosin II minifilament has been measured at
between 230 and 320 nm in length [32–34], about the same
size as the width of a mammalian mitochondrion. However,
considerably smaller myosin II oligomers appear to exist in
cells [35].
Figure 3. Myosin II Enriches at Mitochondrial Constriction Sites
(A) A U2OS cell transfected with mito-BFP and ER-green and then fixed and stained with anti-P-MRLC (myosin regulatory light chain, phosphoserine 19).
Arrowhead shows mitochondrial constriction site. Scale bar represents 10 mm.
(B) U2OS cells labeled with MitoTracker (red), fixed and stained with anti-P-MRLC (green), and imaged by spinning-disk confocal microscopy with five to
seven z sections taken (200 nm z steps). Arrowheads denote constriction sites. Two examples are shown. For each pair, left shows maximum-intensity
image and right shows 3D reconstruction. Scale bar represents 2 mm.
(C) A U2OS cell transfectedwithmito-dsRed andGFP-MIIA and then live imaged by confocal microscopy (single z plane). Arrow points toMIIA accumulation
at the fission site. Scale bar represents 2 mm. See also Movie S1.
(D) Single confocal slices of ‘‘apical’’ mitochondria, located adjacent to the nucleus at >1.4 mm from the ventral surface of the cell, avoiding interference from
abundant ventral stress fibers. U2OS cells were labeledwithMitoTracker (red) and then fixed and stainedwith anti-P-MRLC (green). Cells were left untreated
(left), transfected with siRNA oligos against INF2 for 72 hr (middle), or treated with 0.5 mM latrunculin B for 60 min (right). Scale bar represents 20 mm. See
Figure S3 for quantification of mitochondria-associated P-MRLC puncta in these treatments, as well as close-up images of apical mitochondria, P-MRLC,
and actin filaments.
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412Myosin II involvement in mitochondrial fission is the latest in
a growing relationship between myosins and mitochondrial
dynamics in general. Myosin V is required for propermitochon-
drial distribution in budding yeast, although there is vigorous
debate as to whether this myosin acts to transport mitochon-
dria along actin cables [36] or acts as amitochondrial retention
factor [37]. Interestingly, myosin V depletion actually stimu-
lates axonal mitochondrial motility (both anterograde and
retrograde) in Drosophila neurons, whereas myosin VI deple-
tion stimulates only retrograde motility [38]. In the same
system, myosin V depletion (but not that of myosin VI or
myosin II) increasesmitochondrial length, possibly suggestinga role for myosin V inmitochondrial fission in axonal mitochon-
dria. Another widely expressed myosin, myosin 19, enriches
strongly on mitochondria and acts in mitochondrial motility
in cultured cells, although there is no evidence that it acts in
mitochondrial fission [39]. Finally, myosin II has been impli-
cated in maintenance of the mitochondrial genome, with the
suggestion that both actin and myosin II might be present in
the mitochondrial matrix [40].
The examples described above highlight the potential for
multiple mechanisms controlling mitochondrial dynamics.
For example, the effects of myosin V on mitochondrial size in
Drosophila axons [38] might reflect a fundamentally different
Figure 4. Localization of DRP1 to Mitochondria Is Reduced upon Myosin II Suppression
(A) U2OS cells transfected with control, MIIA, or MIIB siRNAs were treated with MitoTracker (red) and then fixed and immunostained for DRP1 (green).
Zoomed regions are shown in the bottom row. Scale bar represents 10 mm.
(B) Quantification of mitochondrial-associated DRP1 puncta in control and myosin II-suppressed cells. Data are from two experiments; n = 87–110 mito-
chondria. Error bars represent SEM.
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413fission mechanism than that observed in this paper. The pos-
sibility of multiple mechanisms will be useful to keep in mind in
the continued elucidation of fission pathways.
Experimental Procedures
Plasmids and siRNA Oligonucleotides
The human full-length GFP-INF2 CAAX A149D construct was described pre-
viously [5]. The ER-green construct, containing the ER-targeting sequence
(amino acids 233–250) of budding yeast UBC6 [41], was a gift from Victoria
Allan (University of Manchester). Further details are provided in Supple-
mental Experimental Procedures.
Cell Culture, Transfections, and Drug Treatment
U2OS cell lines were grown in DMEM (Invitrogen) supplemented with 10%
calf serum (Atlanta Biologicals). Plasmid transfections were performed in
Opti-MEM media (Invitrogen) with Lipofectamine 2000 (Invitrogen). siRNA
transfections used RNAmax (Invitrogen). Cells were analyzed 24 hr and
72–80 hr posttransfection for DNA and RNAi, respectively. Cells were
treated with MitoTracker Red CMXRos (Invitrogen) at 100 nM in DMEM
20 min prior to fixation. Chemical inhibitor treatments were 50 mM blebbis-
tatin (Sigma-Aldrich), 200 mM CK666 or CK689 (Calbiochem), or 0.5 mM
latrunculin B (Calbiochem). Further details are provided in Supplemental
Experimental Procedures.
Antibodies
Antibodies against nonmuscle MIIA, MIIB, P-MRLC, and Drp1 were from
Cell Signaling. Monoclonal anti-tubulin DM1-a was from Sigma. Secondary
antibodies used were Texas red, Cy5, or fluorescein-conjugated anti-rabbit
immunoglobulin G (Jackson ImmunoResearch Laboratories and Vector
Laboratories, respectively). Further details are provided in Supplemental
Experimental Procedures.
Immunofluorescence Microscopy
Cells were fixed with 4% formaldehyde (Electron Microscopy Sciences) in
PBS for 30 min at room temperature prior to primary and secondary anti-
body treatment. When needed, Alexa Fluor 450-phalloidin (Invitrogen),
TRITC-phalloidin (Sigma-Aldrich), and/or DAPI were added to the second-
ary antibody solution. Samples weremounted on polyvinyl alcohol-DABCO.
Further details are provided in Supplemental Experimental Procedures.
Live Imaging and Confocal Microscopy
Imaging of live and fixed cells was performed using a temperature-
controlled spinning-disk confocal system from Quorum Technologies on aNikon Eclipse Ti microscope. Images and movies were processed using
Nikon Elements and Adobe Photoshop CS. Further details are provided in
Supplemental Experimental Procedures.
Measurements and Image Analysis
To measure mitochondrial length, we created maximum-intensity projec-
tions of z series with 0.2 mm increments for the red channel (MitoTracker
or mito-dsRed). The flat regions of cells with clearly resolved mitochondria
were selected, and 25–30 mitochondria per cell were measured using the
line tool in Nikon Elements software. Drp1 puncta were counted on fixed
cells labeled with anti-Drp1 antibody. To assess P-MRLC localization at
sites of apical mitochondria, we chose a representative confocal slice at
least 1.4 mm from the ventral surface and made a 5 3 5 mm box within the
region containing apical mitochondria. The number of P-MRLC puncta
within this box was counted manually, with a positive punctum defined as
a region < 5 pixels in either dimension whose intensity was clearly above
background. Statistical analysis was performed in Microsoft Excel; data
are presented as mean 6 SE from at least two experiments. Unpaired
Student’s t tests were used to compare values, with p < 0.01 considered sig-
nificant. Further details are provided in Supplemental Experimental
Procedures.
Supplemental Information
Supplemental Information includes four figures, Supplemental Experi-
mental Procedures, and one movie and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2013.12.032.
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